Papers by Elliot Ford
Biomedical NER for the Enterprise with Distillated BERN2 and the Kazu Framework (2022.emnlp-industry)
Copied to clipboard
| Challenge: | a low overall error rate is unavoidable in the field of bioNLP, argues a new study. |
| Approach: | They propose a highly extensible open source framework that supports BioNLP for the pharmaceutical sector. |
| Outcome: | The proposed framework is extensible and scalable and can support BioNLP for the pharmaceutical sector. |